Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.30
+0.21 (4.03%)
Feb 26, 2026, 11:33 AM EST - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $789.25 million as of February 26, 2026. Its market cap has increased by 117.77% in one year.
Market Cap
789.25M
Enterprise Value
593.93M
1-Year Change
117.77%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $789.25M, an increase of 23.41%. That is a compound annual growth rate of 3.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 758.69M | 1.39% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 810.39M |
| Maravai LifeSciences Holdings | 802.92M |
| KalVista Pharmaceuticals | 797.12M |
| Eikon Therapeutics | 797.08M |
| Gyre Therapeutics | 795.29M |
| SELLAS Life Sciences Group | 786.70M |
| MapLight Therapeutics | 783.80M |
| AgomAb Therapeutics NV | 775.40M |